# Stage 6 — Evaluate outcomes. Review the trend after bundled PPH treatment and select the best interpretation and next plan.

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=372475&lang=en  
> language: en  
> subject: Ante/Intra/Postpartum and Newborn Care  
> category: HPM

## Question

Stage 6 — Evaluate outcomes. Review the trend after bundled PPH treatment and select the best interpretation and next plan.

| Time | Data |
| --- | --- |
| Recognition | Fundus soft and shifted right; heavy lochia with clots; QBL 700 mL; BP 92/58; HR 116; pale and lightheaded |
| After massage, bladder emptying, and increased oxytocin | Fundus firms briefly then relaxes; QBL 1,100 mL and rising; BP 88/54; HR 122; delayed capillary refill |
| 15 minutes after expanded bundle | Bimanual compression, TXA, methylergonovine, warmed IV fluid, and continued oxytocin given; fundus firming; lochia decreasing; QBL 1,180 mL; BP 104/66; HR 100 |
| 60 minutes later | Fundus firm and midline; lochia small to moderate without large clots; QBL stable at 1,200 mL; BP 118/72; HR 86; urine output 0.8 mL/kg/hr; alert without lightheadedness |

Q1. How is the client responding to treatment?

Clinically improving with bleeding currently controlled
Stable while bleeding continues at the original rate
Deteriorating with worsening uterine atony and perfusion

Q2. What is the best next plan?

Continue enhanced postpartum surveillance; reassess symptoms, QBL, perfusion, and anemia; provide individualized recovery teaching before determining discharge readiness
Stop surveillance and discharge immediately because the latest blood pressure is normal
Activate MTP now solely because cumulative QBL exceeded 1,000 mL despite controlled bleeding and normalized perfusion
Repeat methylergonovine every 30 minutes and encourage breastfeeding as the primary hemorrhage treatment

## Explanation

Trend interpretation
A firm midline fundus, controlled lochia, plateaued QBL, normalized vital signs, adequate urine output, and resolved lightheadedness show clinical improvement with bleeding controlled. Continue enhanced surveillance, reassess anemia and symptoms, and provide individualized recovery and warning-sign teaching before discharge readiness is determined.

## In-depth explanation

Step 1 — Read the whole trajectory
The uterus becomes firm and midline, lochia decreases, QBL plateaus at 1,200 mL, BP rises, HR falls, urine output is adequate, and lightheadedness resolves. Together these findings support effective hemorrhage control.

Step 2 — Do not overclaim the diagnosis
Response to massage and uterotonics supports uterine atony as the leading working cause, but it does not retrospectively prove that no trauma, retained tissue, or coagulation problem coexisted. Recurrence or new instability requires renewed 4-T evaluation.

Step 3 — Continue postpartum surveillance
After significant hemorrhage, continue fundal, lochia, vital-sign, perfusion, urine-output, symptom, and laboratory reassessment as ordered. Treat postpartum anemia according to symptoms, hemoglobin trajectory, preferences, and protocol. Determine discharge readiness only after sustained stability and provide return precautions and event debriefing.

Step 4 — Medication-specific teaching
Do not use breastfeeding as a substitute for hemorrhage treatment. If methylergonovine was given, follow the product label and facility guidance for blood-pressure monitoring and breastfeeding instructions.

NCLEX rule
Improvement changes the plan from escalation to enhanced surveillance and recovery planning, not immediate discharge.

## Clinical scenario

Scenario (Stage 6 — Evaluate outcomes)
Evaluate whether the bundled response has controlled bleeding and choose safe continuity care.

Clinical judgment target
Use the trajectory rather than one value and avoid treating response as diagnostic proof.

## Key concepts

- **Bleeding controlled** — A clinical trajectory of firm uterine tone, decreasing bleeding, stable QBL, improving perfusion, and no new instability.
- **Postpartum anemia** — Reduced hemoglobin after birth that is managed according to symptoms, laboratory trajectory, hemodynamic stability, preferences, and protocol.
- **Return precautions** — Clear instructions to seek urgent care for recurrent heavy bleeding, syncope, dyspnea, chest pain, worsening weakness, or other concerning symptoms.

## Related questions

- [A nurse is providing preconception counseling to a 28-year-old woman planning a pregnancy …](https://mymerci.kr/pages/nclex_q.php?qn_id=364076&lang=en)
- [A 28-year-old client at 6 weeks gestation, gravida 1 para 0, presents to the prenatal clin…](https://mymerci.kr/pages/nclex_q.php?qn_id=368130&lang=en)
- [Stage 2 — Analyze cues. For each data cluster, select the single role that best explains h…](https://mymerci.kr/pages/nclex_q.php?qn_id=372469&lang=en)
- [Stage 4 — Generate solutions. The client has ongoing atonic postpartum hemorrhage: QBL is …](https://mymerci.kr/pages/nclex_q.php?qn_id=372472&lang=en)
- [Stage 5 — Take action. The PPH response team is at the bedside and concurrent roles have b…](https://mymerci.kr/pages/nclex_q.php?qn_id=372474&lang=en)
- [A nurse assesses a 16-hour-old term newborn and notes visible jaundice on the face and che…](https://mymerci.kr/pages/nclex_q.php?qn_id=372749&lang=en)
- [Review the postpartum follow-up timeline and determine when routine self-care guidance mus…](https://mymerci.kr/pages/nclex_q.php?qn_id=394833&lang=en)
- [A client at 30 weeks of pregnancy received Tdap before conception and asks whether another…](https://mymerci.kr/pages/nclex_q.php?qn_id=396618&lang=en)

## Read in another language

- [en](https://mymerci.kr/pages/nclex_q.php?qn_id=372475&lang=en)
- [ko](https://mymerci.kr/pages/nclex_q.php?qn_id=372475&lang=ko)
- [ja](https://mymerci.kr/pages/nclex_q.php?qn_id=372475&lang=ja)
- [zh-TW](https://mymerci.kr/pages/nclex_q.php?qn_id=372475&lang=zh-tw)
- [vi](https://mymerci.kr/pages/nclex_q.php?qn_id=372475&lang=vi)

---

More free questions: [NCLEX-RN Practice](https://mymerci.kr/pages/nclex_bank.php?lang=en)

_For study reference only. Always follow current clinical guidelines and your institution’s protocols._